Table 1

Patient demographics

Control
(N=56)
VA-LRTI
(N=52)
Age, yearsMedian (IQR)59 (47–67)59 (42–68)
MaleN (%)41 (73.2)31 (59.6)
Days on ICU*Median (IQR)9 (5–13)7 (5–10)
Admission typeMedical—N (%)32 (57.1)18 (34.6)
Emergency surgical—N (%)15 (26.8)16 (30.8)
Planned surgical—N (%)8 (14.3)18 (34.6)
Unscored—N (%)1 (1.8)0 0
TraumaN (%)13 (23.2)20 (38.5)
NeurosurgeryN (%)11 (19.6)16 (30.8)
COPDN (%)6 (10.7)8 (15.4)
ARDSN (%)4 (7.1)0 (0)
CPISMedian (IQR)5 (4–6)7 (5.8–7)
APACHE IIMedian (IQR)20 (15–23)17 (11–22)
Temperature, °CMedian (IQR)38 (37–39)38 (37–38)
WCC, 109/LMedian (IQR)15 (10–21)13 (12–18)
PaO2/FiO2, mm HgMedian (IQR)232 (156–270)240 (171–284)
Pmax, cmH2OMedian (IQR)20 (16–25)21 (16–24)
PEEP, cmH2OMedian (IQR)8 (5–10)7.5 (5–10)
Tidal volume, mLMedian (IQR)476 (417–550)487 (411–602)
Confirmed VA-LRTIVAP—N (%)41 (79)
VAT—N (%)11 (21)
Culture results†N (%)
Acinetobacter pittii 1 (1.9)
Enterobacter cloacae 2 (3.8)
Escherichia coli 3 (5.8)
Haemophilus influenzae 5 (9.6)
Klebsiella spp6 (11.5)
Pseudomonas aeruginosa 9 (17.3)
Serratia marcescens 2 (3.8)
Staphylococcus aureus15 (28.8)
Stenothrophomas maltophilia 2 (3.8)
Other7 (13.4)
ICU LOS, daysMedian (IQR)22 (14–33)21 (15–32)
Hospital LOS, daysMedian (IQR)31 (15–44)30 (19–57)
ICU mortalityN (%)17 (30.4)9 (17.3)
  • Continuous variables are expressed as median (25th–75th percentile); categorical variables as number of patients (percentage).

  • *Days on ICU until VA-LRTI suspicion.

  • †Potentially >1 cultured pathogen per patient.

  • ‡All methicillin sensitive.

  • APACHE, Acute Physiology and Chronic Health Evaluation; ARDS, acute respiratory distress syndrome; CPIS, Clinical Pulmonary Infection Score; FiO2, inspired fraction of oxygen ratio; ICU, intensive care unit; LOS, length of stay; PEEP, positive end-expiratory pressure; Pmax, maximum airway pressure; VA-LRTI, ventilator-associated lower respiratory tract infection; VAP, ventilator-associated pneumonia; VAT, ventilator-associated tracheobronchitis; WCC, white cell count.